CFH rs3916967: Understanding Your Genetic Marker
The rs3916967 variant is a single-nucleotide polymorphism located within the CFH gene, which plays a critical role in the body's immune response. It is frequently studied as a marker co-inherited in haplotypes that may modulate an individual's risk for developing late-stage age-related macular degeneration (AMD).
What each genotype means
Baseline risk profile
This genotype represents the common form of this marker in the CFH gene. Research indicates this variant is often part of larger genetic patterns that may influence susceptibility to age-related macular degeneration, though the specific impact of this individual marker is considered limited. Please note that macular health is influenced by many genetic and environmental factors, and this result does not constitute a medical diagnosis.
Carried by approximately 45% of individuals of European ancestry, based on a minor allele frequency of roughly 0.33.
Intermediate risk profile
Carrying one copy of this variant means you possess a genetic marker frequently studied in the context of age-related macular degeneration. Because this marker is often co-inherited with other genetic changes in the CFH gene, its individual contribution to vision health is difficult to isolate and is currently classified as limited. You should discuss any concerns regarding your eye health or family history with an eye care professional.
Carried by approximately 44% of individuals of European ancestry.
Elevated risk marker
This genotype is associated with the variant allele that is frequently tracked in research regarding age-related macular degeneration. While this marker is often found in haplotypes that modulate risk, the evidence for this specific variant's independent effect is limited. Genetic markers are only one component of eye health, and you should consult with an ophthalmologist for personalized screening or preventative advice.
Carried by approximately 11% of individuals of European ancestry.
What is rs3916967 and Where is it Located?
The variant rs3916967 is a specific change in the DNA sequence found within the CFH gene. In genomics, a single-nucleotide polymorphism (SNP) like this represents a variation at a single position in the DNA building blocks. The CFH gene is located on the long arm of chromosome 1 at position 1q31.3. This region is highly significant in genetic research because it contains the Regulator of Complement Activation (RCA) gene cluster. Because rs3916967 is often inherited alongside other nearby variants as part of a haplotype—a set of DNA variations that tend to be passed down together—researchers often analyze it to understand how these combined genetic patterns influence health outcomes. It is important to note that being a marker, this SNP may not be the direct cause of a condition but rather a signpost for other functional changes in the surrounding genomic neighborhood.
The Role of the CFH Gene
The CFH gene provides instructions for making a protein called complement factor H. This protein is a vital component of the complement system, which is a part of the body's innate immune response. The complement system helps clear out pathogens and damaged cells, but it must be tightly regulated to prevent it from attacking the body's own healthy tissues. Complement factor H acts as a 'brake' on this system, preventing excessive inflammation and tissue damage. When the CFH gene functions optimally, it helps maintain the health of various tissues, including the retina in the eye. Disruptions or variations in this gene can lead to an overactive immune response, which is hypothesized to contribute to the development of inflammatory conditions. Understanding how variants like rs3916967 relate to the function of this protein is a major focus of ongoing research into ocular health and immune regulation.
Research Associations and Evidence Strength
Scientific research has identified associations between variants in the CFH gene and age-related macular degeneration (AMD), a condition that affects the central part of the retina. While some variants in this gene have strong, well-documented links to AMD risk, the evidence for rs3916967 specifically is considered limited. Many studies focus on how this SNP acts as a marker for broader haplotypes that influence disease susceptibility. It is crucial to understand that genetic association does not equal causation. While statistical models show that certain genotypes appear more frequently in individuals with AMD, these findings are often ancestry-specific and may not apply universally across all populations. Furthermore, AMD is a complex, multifactorial condition influenced by a combination of genetics, environmental factors, and lifestyle choices. Therefore, the presence of a specific genotype at this location should not be viewed as a definitive predictor of future health outcomes.
Population Frequency
The frequency of genetic variants can vary significantly depending on an individual's ancestral background. For rs3916967, the minor allele frequency (MAF) is approximately 0.33 in European cohorts. This means that the variant is relatively common in these populations. However, it is important to recognize that frequency data is often derived from specific study groups, and these numbers may differ in other global populations. Genetic diversity means that a variant common in one group might be rare or absent in another. Researchers use this frequency data to help determine if a variant is likely to be a significant contributor to a disease or if it is simply a common feature of human genetic variation. Because this variant is common, it is often used in large-scale genomic studies to help map out the complex architecture of the CFH gene region.
What You Can and Cannot Do With This Information
Genetic information regarding variants like rs3916967 is intended for educational purposes and should not be used for medical diagnosis or personal health management. You cannot use this information to predict whether you will develop a specific eye condition, as genetics is only one piece of a much larger puzzle. If you are concerned about your vision or have a family history of macular degeneration, the most effective step is to consult with an eye care professional, such as an ophthalmologist or optometrist. They can provide comprehensive screenings and personalized advice based on your clinical history and current eye health. Avoid making health decisions based solely on genetic reports, as they lack the context of your overall medical profile. Always discuss any concerns about genetic testing results with a qualified healthcare provider or a genetic counselor who can help interpret the findings in a meaningful way.
How common is this variant?
The rs3916967 variant has a minor allele frequency of approximately 0.33 in European cohorts, making it a relatively common genetic marker in these populations.
Frequently asked questions
Is rs3916967 a direct cause of macular degeneration?
No, rs3916967 is considered a genomic marker. It is often studied because it is co-inherited with other variants that may influence risk, but it is not established as a direct cause of the condition.
Should I be worried if I have the risk genotype for this SNP?
Genetic associations are statistical, not diagnostic. Having a specific genotype does not mean you will develop a condition, and you should consult an eye care professional for a clinical assessment of your actual eye health.
Does this variant affect everyone the same way?
No, the impact of genetic variants can vary significantly based on ancestry, environment, and other lifestyle factors. Research findings on this SNP are primarily based on European cohorts and may not apply to all populations.
Where can I find more information about my eye health?
For personalized information, you should speak with an ophthalmologist or optometrist. They can perform clinical exams that are far more predictive of your eye health than genetic testing alone.
Sources & further reading
Educational information only, last refreshed 10/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3916967?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CFH
This variant in the complement factor H gene is associated with altered regulation of the alternative complement pathway and increased susceptibility to age-related macular degeneration.
This regulatory variant in the CFH locus is linked to complement system dysregulation and is a recognized genetic risk factor for age-related macular degeneration.
Intronic single nucleotide variant in the CFH region associated with susceptibility to age-related macular degeneration (AMD).
Common variant in the CFH locus strongly associated with risk of age-related macular degeneration (AMD).
Intronic marker in CFH forming critical susceptibility haplotypes for choroidal neovascularization and macular atrophy.
Intergenic/intronic variant within the CFH cluster contributing to phenotypic variation in retinal complement activation.